Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
PGC - 1α (205–216), Proliferator - activated Receptor Coactivator - 1 α (205–216)
PGC - 1α (205–216), Proliferator - activated Receptor Coactivator - 1 α (205–216)
CAS No. ———
PGC - 1α (205–216), Proliferator - activated Receptor Coactivator - 1 α (205–216)( ——— )
Catalog No. M41547 CAS No. ———
PGC - 1α (205–216), Proliferator - activated Receptor Coactivator - 1 α (205–216)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePGC - 1α (205–216), Proliferator - activated Receptor Coactivator - 1 α (205–216)
-
NoteResearch use only, not for human use.
-
Brief DescriptionPGC - 1α (205–216), Proliferator - activated Receptor Coactivator - 1 α (205–216)
-
DescriptionPGC - 1α (205–216), Proliferator - activated Receptor Coactivator - 1 α (205–216)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1464.75
-
Molecular FormulaC65H109N17O19S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
KISS1-305
KISS1-305, the Metastin/Kisspeptin analog, is a prototype peptide and a chemical probe. KISS1-305 has suboptimal KISS1R agonistic activity, and resists plasma protease degradation.KISS1-305 is a proto- type peptide that resists plasma protease degradation but has suboptimal KISS1R agonistic activity in vitro.
-
1-O-galloyl-6-O-cinn...
1-O-galloyl-6-O-cinnamoylglucose is a natural product for research related to life sciences.
-
Marginatoxin
Marginatoxin may be a promising chemopreventive agent for treating hepatocellular carcinoma, it induces human hepatoma BEL-7402 cells apoptosis in vitro and in vivo via activation of Fas/FasL-mediated apoptotic pathway.
